Open AccessOpaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial
Author(s) -
Kevin Winthrop,
Alan Skolnick,
Adnan Rafiq,
Scott Beegle,
Julian Suszanski,
Guenther Koehne,
Ofra BarnettGriness,
Aida Bibliowicz,
Reza Fathi,
Patricia J. Anderson,
Gilead Raday,
Gina Eagle,
Vered Katz Ben-Yair,
Harold S. Minkowitz,
Mark L. Levitt,
Michael S. Gordon
Publication year - 2022
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofac232
Subject(s) - medicine , placebo , pneumonia , adverse effect , randomized controlled trial , covid-19 , disease , pathology , infectious disease (medical specialty) , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom